pimobendan has been researched along with h 89 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Chen, CH; Kubo, M; Minami, K; Nakaya, Y | 1 |
| Kimura, T; Kuwashima, H; Matsumura, C | 1 |
3 other study(ies) available for pimobendan and h 89
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Effects of pimobendan and its active metabolite, UD-CG 212 Cl, on Ca2+-activated K+ channels in vascular smooth-muscle cells.
Topics: Animals; Calcium; Cardiotonic Agents; Coronary Vessels; Drug Interactions; Enzyme Inhibitors; Heart; Isoquinolines; Muscle, Smooth, Vascular; Potassium Channels; Pyridazines; Sulfonamides; Swine; Vasodilation | 1997 |
Inhibition and facilitation by pimobendan, a calcium sensitizer, of catecholamine secretion from bovine adrenal chromaffin cells.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acetylcholine; Adrenal Glands; Amrinone; Angiotensin II; Animals; Calcium; Catecholamines; Cattle; Cells, Cultured; Chromaffin Cells; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 3; Dimethylphenylpiperazinium Iodide; Histamine; Isoquinolines; Milrinone; Potassium; Pyridazines; Sulfonamides | 2003 |